{
  "docId": "019de071-e0d6-76fb-ba84-d69d61ac5ee5",
  "docSlug": "1773642d94b9dc79507cf930970e5456",
  "documentTitle": "Certara | Investor Day Presentation Deck | 91 slides",
  "authorId": "certara",
  "authorName": "Certara",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 91,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 14,
  "notes": "The slide uses a bar chart for historical data and a word cloud for 2021 examples.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-e0d6-76fb-ba84-d69d61ac5ee5/20",
  "deckHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5",
  "deckJsonHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5.json",
  "deckAnchorHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "FDA Novel Drug Approvals Received by Our Clients 2014 - 2020",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d550c5b9-0664-4c4d-91b4-4ebc1486e4d9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "image",
      "text": "2021 Novel Drug Approvals Using Certara Solutions (Word Cloud)",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13c74040-9678-43fb-b700-dd62c23dd312",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "Our customers, who use our software and technology-driven services, have received 90% of FDA drug approvals for 7 consecutive years.*",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d252c451-a243-4df7-9a72-6df90c183304",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.03,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "*Excludes diagnostics. Orphan designation applies across therapeutic areas.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09cba481-c4f7-4763-959e-b0ae09c1c38c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.5,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Drug approvals using biosimulation",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e533147-610c-4f2b-bc4a-d1cc0d3d2585",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "9fc92459-6b62-4d93-8795-2faed373ada7",
      "evidence": "Our customers, who use our software and technology-driven services, have received 90% of FDA drug approvals for 7 consecutive years.*",
      "confidence": 0.7
    },
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "8dc6dfb3-f6b5-4d99-b683-8b6c6d44b275",
      "evidence": "2021 Novel Drug Approvals Using Certara Solutions (Word Cloud)",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 12,
      "beatId": "3febb1b1-76b6-4466-a201-7c24a01e3217",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "Pain points in clinical phase and complexity of drug R&D are highlighted",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 12,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "aefb73c8-4528-41b5-be1f-4d7ee4e62081",
      "evidence": "The deck highlights the costs and complexities of traditional drug R&D",
      "position": 0,
      "objective": "What are the costs of not using biosimulation?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}